Protalix BioTherapeutics, Inc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (41)

Latest Posts

About This Stock More About This Stock
E There Is Beta In Protalix Stock Due To PRX-102
Article By: Moon Kil Woong
Monday, August 31, 2020 9:29 AM EST
Protalix offers positive Beta on PRX-102 success.
In this article: PLX Also: SNY
Protalix BioTherapeutics Announces FDA Acceptance Of BLA For The Treatment Of Fabry Disease And Grants Priority Review
Article By: TalkMarkets Newswire
Tuesday, August 11, 2020 9:05 AM EST
Priority Review is granted to therapies that the FDA determines have the potential to provide significant improvements in the treatment, diagnosis or prevention of serious conditions.
In this article: PLX Also: IMMP, SRNE, TTOO, OPGN, OXBR
E Protalix BioTherapeutics Pipeline Progress
Article By: Terry Chrisomalis
Wednesday, July 29, 2020 9:54 AM EST
Protalix Biotherapeutics (PLX) offers great potential in the coming months as its lead candidate, PLX-102 - a therapy for Fabry disease, is edging closer to the finish line.
In this article: PLX, SNY Also: ITMR, BLRX, BCLI, BLPH, PSTI
Premarket Biotech Digest – NOVN Reports Topline Results, INNV Receives New Patent, AIQ Signs Merger Agreement
Article By: KKD Healthcare Analytics
Wednesday, April 12, 2017 9:50 AM EST
Novan stock skyrocketed as the company reported positive topline results from the Company’s Phase 2 clinical trial with SB208. Alliance HealthCare Services announced signing a definitive merger agreement with Tahoe Investment Group.
In this article: AIQ, PLX, AVEO, BCRX, NBIX, MZOR, NOVN
Morning Call For Tuesday, Dec. 27
Article By: Jim Van Meerten
Tuesday, December 27, 2016 9:46 AM EST
Mar E-mini S&Ps (ESH17 +0.06%) are up +0.06% and European stocks are up +0.10% in thin holiday trade. Markets in the UK, Australia and Hong Kong are closed today for holiday.
In this article: BID, DIS, DV, LGF, RBA, WLL, PLX, HOLX, SHPG, MGNX

Latest Tweets for $PLX

No tweets yet!


There Is Beta In Protalix Stock Due To PRX-102
Stock Profit 8/31/2020 2:14:57 PM

I'm liking what I see about $PLX!

There Is Beta In Protalix Stock Due To PRX-102
Daniel Charles 8/31/2020 5:32:09 AM

Are there any other recombinant therapeutics that are in the pipeline for $PLX

There Is Beta In Protalix Stock Due To PRX-102
Cannabis Stock Buyer 8/31/2020 4:59:17 AM

I'll be taking a closer look at $PLX, thanks.

Protalix BioTherapeutics Pipeline Progress
Richard M. Clark 8/28/2020 2:40:47 AM

Just read another good article about $PLX out today:

There Is Beta In Protalix Stock Due To PRX-102

There Is Beta In Protalix Stock Due To PRX-102
Bruce Powers 8/27/2020 8:43:08 PM

$PLX sounds like a promising company

Protalix BioTherapeutics Pipeline Progress
Dave Schneider 8/26/2020 3:29:13 PM

Thanks for your thoughts. I'm interested in this company but would like to see more info about $PLX before investing. However, good coverage seems to be sparse.

Protalix BioTherapeutics Pipeline Progress
Harry Goldstein 8/10/2020 6:01:37 AM

#Protalix clearly has a lot of potential but there's a limited number of people who will need this drug. So the real question is how much of a dent will they put into #Sanofi's market share. $PLX $SNY

Protalix BioTherapeutics Pipeline Progress
Old Time Investor 8/3/2020 2:23:12 PM

My pleasure. What's more important than how prevalent the disease is, is how much money #Protalix can make on its new drug. It's competitor, #Sanofi ($SNY) makes $1 billion in revenue annually on their drug. Protalix's sounds like a more promising alternative. I'd definitely rate $PLX a buy.

Protalix BioTherapeutics Pipeline Progress
Andrew Armstrong 7/29/2020 8:51:38 PM

Good article, nicely done. I will be checking out $PLX.

Protalix BioTherapeutics Pipeline Progress
John Doee 7/29/2020 6:13:09 PM

Thank you for this article. Are there any other recombinant therapeutics that are in the pipeline for them? $PLX

1 to 10 of 11 comments
1 2